1. Home
  2. JYNT vs OABI Comparison

JYNT vs OABI Comparison

Compare JYNT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • OABI
  • Stock Information
  • Founded
  • JYNT 2010
  • OABI 2012
  • Country
  • JYNT United States
  • OABI United States
  • Employees
  • JYNT N/A
  • OABI N/A
  • Industry
  • JYNT Multi-Sector Companies
  • OABI Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • OABI Health Care
  • Exchange
  • JYNT Nasdaq
  • OABI Nasdaq
  • Market Cap
  • JYNT 170.1M
  • OABI 198.2M
  • IPO Year
  • JYNT 2014
  • OABI N/A
  • Fundamental
  • Price
  • JYNT $11.52
  • OABI $1.60
  • Analyst Decision
  • JYNT Strong Buy
  • OABI Strong Buy
  • Analyst Count
  • JYNT 2
  • OABI 3
  • Target Price
  • JYNT $15.50
  • OABI $7.00
  • AVG Volume (30 Days)
  • JYNT 65.4K
  • OABI 1.1M
  • Earning Date
  • JYNT 08-07-2025
  • OABI 08-07-2025
  • Dividend Yield
  • JYNT N/A
  • OABI N/A
  • EPS Growth
  • JYNT N/A
  • OABI N/A
  • EPS
  • JYNT N/A
  • OABI N/A
  • Revenue
  • JYNT $52,789,479.00
  • OABI $26,744,000.00
  • Revenue This Year
  • JYNT $9.72
  • OABI N/A
  • Revenue Next Year
  • JYNT $10.92
  • OABI $45.65
  • P/E Ratio
  • JYNT N/A
  • OABI N/A
  • Revenue Growth
  • JYNT 71.05
  • OABI 27.07
  • 52 Week Low
  • JYNT $9.58
  • OABI $1.22
  • 52 Week High
  • JYNT $15.32
  • OABI $4.96
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 53.47
  • OABI 54.70
  • Support Level
  • JYNT $11.48
  • OABI $1.35
  • Resistance Level
  • JYNT $12.49
  • OABI $1.81
  • Average True Range (ATR)
  • JYNT 0.86
  • OABI 0.10
  • MACD
  • JYNT -0.04
  • OABI 0.04
  • Stochastic Oscillator
  • JYNT 42.66
  • OABI 71.96

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: